Evidence map›Paper›PMID 26090434›Full record

ArticleBioMed research international2015

Mass Spectral Profile for Rapid Differentiating Beta-Lactams from Their Ring-Opened Impurities.

Hecheng Wang, Haiwei Huang, Jin Cao, Dehua Chui, Shengyuan Xiao

Open access · hybridAbstract read
In one paragraph

Article in BioMed research international, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.

0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact, top 98% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

0 citing papers in PubMed, 4 citations in OpenAlex.

No citing paper in PubMed yet.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

5 authors at 3 institutions in 1 country.

Hecheng WangSchool of Life Science, Beijing Institute of Technology, 5 Zhongguancun Street, South Haidian District, Beijing 100081, China ; Neuroscience Research Institute, Health Science Center, Peking University, Beijing 100191, China.
Haiwei HuangNational Institutes for Food and Drug Control, Beijing 100050, China.
Jin CaoNational Institutes for Food and Drug Control, Beijing 100050, China.
Dehua ChuiNeuroscience Research Institute, Health Science Center, Peking University, Beijing 100191, China.
Shengyuan XiaoSchool of Life Science, Beijing Institute of Technology, 5 Zhongguancun Street, South Haidian District, Beijing 100081, China.ORCID 0000-0002-0039-8325
Beijing Institute of Technology · CNNational Institutes for Food and Drug Control · CNPeking University · CN

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

High performance liquid chromatography tandem mass spectrometry (HPLC MS) has been widely used for β-lactam antibiotics determination. However, its application to identify impurities of these frequently used drugs is not sufficient at present. In this job, characteristic profiles of the collision induced dissociation (CID) spectra of both β-lactams and ring-opened β-lactams were extracted from the MS data of six β-lactam antibiotics and their forty-five impurities, and were confirmed by the MS data reported in the literature. These characteristics have been successfully applied to rapid differentiation of β-lactam and ring-opened β-lactam impurities in cefixime, cefdinir, and cefaclor. However, these characteristic profiles can only be obtained under low activating voltage. They did not display in the high energy activated CID spectra. Diagnostic fragmentations for determining the localization of double bond and substituents on the thiazine ring and the side chain were also observed. In addition, several characteristic fragmentations are hopeful to be used to differentiate the configurations of C-2 on the thiazine ring of ring-opened impurities, which is generally disadvantageous of mass spectrometry. Taken together, forty-five impurities were identified from the capsules of cefixime, cefdinir, and cefaclor.

Indexed as

Mass SpectrometryAnti-Bacterial Agentsbeta-LactamsCefaclorCefdinirCefiximeCephalosporinsChromatography, High Pressure LiquidHumansAnti-Bacterial Agentsbeta-LactamsCefaclorCefdinirCefiximeCephalosporins

Identifiers

PMID26090434
PMCPMC4450268
OpenAlexW1545666913

What OpenQuestion holds

Textmetadata
LicenceCC BY
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.